Meningococcal Vaccines Market Report

Global Meningococcal Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 09, 2022
  • PAGES：168
  • REPORT CODE：GMM802713
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Meningococcal Vaccines market report explains the definition, types, applications, major countries, and major players of the Meningococcal Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sanofi

    • Pfizer

    • Novartis International

    • Baxter International

    • GlaxoSmithKline

    • JN-International Medical

    By Type:

    • Menactra

    • Menomune

    By End-User:

    • Pneumonia

    • Meningitis

    • Bacteremia

    • Others (Arthritis, Conjunctivitis, Urethritis)

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Meningococcal Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Meningococcal Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Meningococcal Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Meningococcal Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Meningococcal Vaccines Market- Recent Developments

    • 6.1 Meningococcal Vaccines Market News and Developments

    • 6.2 Meningococcal Vaccines Market Deals Landscape

    7 Meningococcal Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Meningococcal Vaccines Key Raw Materials

    • 7.2 Meningococcal Vaccines Price Trend of Key Raw Materials

    • 7.3 Meningococcal Vaccines Key Suppliers of Raw Materials

    • 7.4 Meningococcal Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Meningococcal Vaccines Cost Structure Analysis

      • 7.5.1 Meningococcal Vaccines Raw Materials Analysis

      • 7.5.2 Meningococcal Vaccines Labor Cost Analysis

      • 7.5.3 Meningococcal Vaccines Manufacturing Expenses Analysis

    8 Global Meningococcal Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Meningococcal Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Meningococcal Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Meningococcal Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Meningococcal Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Menactra Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Menomune Consumption and Growth Rate (2017-2022)

    • 9.2 Global Meningococcal Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pneumonia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Meningitis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Bacteremia Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others (Arthritis, Conjunctivitis, Urethritis) Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Meningococcal Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Meningococcal Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Meningococcal Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Meningococcal Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Meningococcal Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Meningococcal Vaccines Consumption (2017-2022)

      • 10.3.2 UK Meningococcal Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Meningococcal Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Meningococcal Vaccines Consumption (2017-2022)

      • 10.3.5 France Meningococcal Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Meningococcal Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Meningococcal Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Meningococcal Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Meningococcal Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Meningococcal Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Meningococcal Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Meningococcal Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Meningococcal Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Meningococcal Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Meningococcal Vaccines Consumption (2017-2022)

      • 10.4.3 India Meningococcal Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Meningococcal Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Meningococcal Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Meningococcal Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Meningococcal Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Meningococcal Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Meningococcal Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Meningococcal Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Meningococcal Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Meningococcal Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Meningococcal Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Meningococcal Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Meningococcal Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Meningococcal Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Meningococcal Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Meningococcal Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Meningococcal Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Meningococcal Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Meningococcal Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Meningococcal Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Meningococcal Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Meningococcal Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Meningococcal Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Meningococcal Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Meningococcal Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Meningococcal Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Meningococcal Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Meningococcal Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Meningococcal Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Meningococcal Vaccines Consumption (2017-2022)

    11 Global Meningococcal Vaccines Competitive Analysis

    • 11.1 Sanofi

      • 11.1.1 Sanofi Company Details

      • 11.1.2 Sanofi Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sanofi Meningococcal Vaccines Main Business and Markets Served

      • 11.1.4 Sanofi Meningococcal Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Pfizer

      • 11.2.1 Pfizer Company Details

      • 11.2.2 Pfizer Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Pfizer Meningococcal Vaccines Main Business and Markets Served

      • 11.2.4 Pfizer Meningococcal Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Novartis International

      • 11.3.1 Novartis International Company Details

      • 11.3.2 Novartis International Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Novartis International Meningococcal Vaccines Main Business and Markets Served

      • 11.3.4 Novartis International Meningococcal Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Baxter International

      • 11.4.1 Baxter International Company Details

      • 11.4.2 Baxter International Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Baxter International Meningococcal Vaccines Main Business and Markets Served

      • 11.4.4 Baxter International Meningococcal Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 GlaxoSmithKline

      • 11.5.1 GlaxoSmithKline Company Details

      • 11.5.2 GlaxoSmithKline Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 GlaxoSmithKline Meningococcal Vaccines Main Business and Markets Served

      • 11.5.4 GlaxoSmithKline Meningococcal Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 JN-International Medical

      • 11.6.1 JN-International Medical Company Details

      • 11.6.2 JN-International Medical Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 JN-International Medical Meningococcal Vaccines Main Business and Markets Served

      • 11.6.4 JN-International Medical Meningococcal Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    12 Global Meningococcal Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Meningococcal Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Menactra Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Menomune Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Meningococcal Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pneumonia Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Meningitis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Bacteremia Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others (Arthritis, Conjunctivitis, Urethritis) Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Meningococcal Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Meningococcal Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Meningococcal Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Meningococcal Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Meningococcal Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Meningococcal Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Meningococcal Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Meningococcal Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Meningococcal Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Meningococcal Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Meningococcal Vaccines

    • Figure of Meningococcal Vaccines Picture

    • Table Global Meningococcal Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Meningococcal Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Menactra Consumption and Growth Rate (2017-2022)

    • Figure Global Menomune Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumonia Consumption and Growth Rate (2017-2022)

    • Figure Global Meningitis Consumption and Growth Rate (2017-2022)

    • Figure Global Bacteremia Consumption and Growth Rate (2017-2022)

    • Figure Global Others (Arthritis, Conjunctivitis, Urethritis) Consumption and Growth Rate (2017-2022)

    • Figure Global Meningococcal Vaccines Consumption by Country (2017-2022)

    • Table North America Meningococcal Vaccines Consumption by Country (2017-2022)

    • Figure United States Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Meningococcal Vaccines Consumption by Country (2017-2022)

    • Figure Germany Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Meningococcal Vaccines Consumption by Country (2017-2022)

    • Figure China Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Meningococcal Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Meningococcal Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Meningococcal Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Meningococcal Vaccines Consumption by Country (2017-2022)

    • Figure Australia Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Meningococcal Vaccines Consumption and Growth Rate (2017-2022)

    • Table Sanofi Company Details

    • Table Sanofi Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Meningococcal Vaccines Main Business and Markets Served

    • Table Sanofi Meningococcal Vaccines Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Meningococcal Vaccines Main Business and Markets Served

    • Table Pfizer Meningococcal Vaccines Product Portfolio

    • Table Novartis International Company Details

    • Table Novartis International Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International Meningococcal Vaccines Main Business and Markets Served

    • Table Novartis International Meningococcal Vaccines Product Portfolio

    • Table Baxter International Company Details

    • Table Baxter International Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter International Meningococcal Vaccines Main Business and Markets Served

    • Table Baxter International Meningococcal Vaccines Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Meningococcal Vaccines Main Business and Markets Served

    • Table GlaxoSmithKline Meningococcal Vaccines Product Portfolio

    • Table JN-International Medical Company Details

    • Table JN-International Medical Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table JN-International Medical Meningococcal Vaccines Main Business and Markets Served

    • Table JN-International Medical Meningococcal Vaccines Product Portfolio

    • Figure Global Menactra Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Menomune Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumonia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meningitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bacteremia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others (Arthritis, Conjunctivitis, Urethritis) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meningococcal Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Meningococcal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Meningococcal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Meningococcal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Meningococcal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Meningococcal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Meningococcal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Meningococcal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US